<?xml version="1.0"?>

<document>
	<title>Letter: Na+ transport defect in cystic fibrosis.</title>

	<author>Duffy-M-J.</author>

	<source>Nature. 1974 May 3. 249(452). P 94-5.</source>

	<abstract>Using the technique of 3H-ouabain binding to isolate cells Quissell
   and Pitot concluded that the Na+-K+ ATPase functions normally in
   fibroblasts from cystic fibrosis patients.  However this finding
   may not be very relevant to the Na+ transport defect occurring in
   this genetic disease.  The Na+ transport abnormality in cystic
   fibrosis seems to be confined to exocrine glands.  It is unknown at
   present whether the defect resides in an active or passive
   transport step of the cation.  At least with isolated sweat gland
   tissue and erythrocytes from cystic fibrosis patients, Na+-K+
   ATPase activity has been found to be normal.  However a decrease in
   the ethacrynic acid-sensitive efflux, a Na+ exchange mechanism, has
   been reported in cystic fibrosis erythrocytes.  These findings
   suggest that there is no fundamental abnormality in the Na+-K+
   ATPase enzyme in the disease, but there may be a defect in an
   ethacrynic acid-sensitive transport step.  Therefore in order to
   obtain a better understanding of the cation transport defect one
   should measure the binding of labelled ethacrynic-acid rather than
   ouabain.</abstract>

	<majorsubject>CYSTIC-FIBROSIS: me</majorsubject>
	<majorsubject>SODIUM: me</majorsubject>

	<minorsubject>ADENOSINE-TRIPHOSPHATASE: me</minorsubject>
	<minorsubject>BIOLOGICAL-TRANSPORT: de</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: en</minorsubject>
	<minorsubject>ERYTHROCYTES: me</minorsubject>
	<minorsubject>ETHACRYNIC-ACID: pd</minorsubject>
	<minorsubject>FIBROBLASTS: me</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>OUABAIN</minorsubject>
	<minorsubject>TRITIUM</minorsubject>

	<reference>001   QUISSELL DO           NATURE                         247   115 974</reference>
	<reference>002   DI SANTAGNESE PA      N ENGL J MED                   277  1344 967</reference>
	<reference>003   GIBBS GE              PEDIATR RES                      1    24 967</reference>
	<reference>004   HORTON CR             BIOCHEM BIOPHYS RES COMMUN      40   505 970</reference>
	<reference>005   DUNN MJ               J CLIN INVEST                   49  1815 970</reference>
	<reference>006   BALFE JW              SCIENCE                        162   689 968</reference>
	<reference>007   LAPEY A               PEDIATR RES                      5   446 971</reference>
	<reference>008   DUFFY MJ              LANCET                           2   136 972</reference>
	<reference>009   DUFFY MJ              CLIN CHIM ACTA                  49   397 973</reference>
	<reference>010   ORLOFF J              AM J MED                        42   757 967</reference>
	<reference>011   WEISMAN UN            LANCET                           1   510 972</reference>
	<reference>012   WIESMANN UN           J PEDIATR                       76   444 970</reference>
	<reference>013   HADDEN JW             PROC SOC EXP BIOL MED          142   577 973</reference>
	<reference>014   EPSTEIN RW            BIOCHIM BIOPHYS ACTA           274   119 972</reference>
	<reference>015   SATO K                PFLUEGERS ARCH                 341   233 973</reference>
	<reference>016   EPSTEIN RW            BIOCHIM BIOPHYS ACTA           274   119 972</reference>
	<reference>017   SIMOPOULOS AP         PEDIATR RES                      5   626 971</reference>

	<citation>1   BOUCHER RC            PEDIATR RES                     18  1336 984</citation>

</document>
